1,816
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The first suspected disseminated Hormographiella aspergillata infection in China, diagnosed using metagenomic next-generation sequencing: a case report and literature review

, , , , , , , , & ORCID Icon show all
Article: 2220581 | Received 19 Sep 2022, Accepted 29 May 2023, Published online: 11 Jun 2023

References

  • Lamoth F, Kontoyiannis DP. Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients. Antimicrob Agents Chemother. 2019;63(11):e01244–19. doi:10.1128/AAC.01244-19
  • Oliveira TB, Lopes VCP, Barbosa FN, et al. Fungal communities in pressmud composting harbour beneficial and detrimental fungi for human welfare. Microbiology. 2016;162(7):1147–1156. doi:10.1099/mic.0.000306
  • Kües U. Life history and developmental processes in the basidiomycete Coprinus cinereus. Microbiol Mol Biol Rev. 2000;64(2):316–353. doi:10.1128/MMBR.64.2.316-353.2000
  • Gené J, Guillamón JM, Guarro J, et al. Molecular characterization, relatedness and antifungal susceptibility of the basidiomycetous Hormographiella species and Coprinus cinereus from clinical and environmental sources. Antonie Leeuwenhoek. 1996;70(1):49–57. doi:10.1007/BF00393569
  • Chowdhary A, Kathuria S, Agarwal K, et al. Recognizing filamentous basidiomycetes as agents of human disease: a review. Med Mycol. 2014;52(8):782–797. doi:10.1093/mmy/myu047
  • Verweij PE, van Kasteren M, van de Nes J, et al. Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata. J Clin Microbiol. 1997;35(10):2675–2678. doi:10.1128/jcm.35.10.2675-2678.1997
  • Nenoff P, Friedrich T, Schwenke H, et al. Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the basidiomycete Coprinus sp. in a leukemic patient. J Med Vet Mycol. 1997;35(1):65–69. doi:10.1080/02681219780000901
  • Surmont I, Van Aelst F, Verbanck J, et al. A pulmonary infection caused by Coprinus cinereus (Hormographiella aspergillata) diagnosed after a neutropenic episode. Med Mycol. 2002;40(2):217–219. doi:10.1080/mmy.40.2.217.219
  • Lagrou K, Massonet C, Theunissen K, et al. Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. J Med Microbiol. 2005;54(7):685–688. doi:10.1099/jmm.0.46016-0
  • Abuali MM, Posada R, Del Toro G, et al. Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol. 2009;47(12):4176–4179. doi:10.1128/JCM.00305-09
  • Conen A, Weisser M, Hohler D, et al. Hormographiella aspergillata: an emerging mould in acute leukaemia patients? Clin Microbiol Infect. 2011;17(2):273–277. doi:10.1111/j.1469-0691.2010.03266.x
  • Suarez F, Olivier G, Garcia-Hermoso D, et al. Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin. J Clin Microbiol. 2011;49(1):461–465. doi:10.1128/JCM.01213-10
  • Pang KA, Godet C, Fekkar A, et al. Breakthrough invasive mould infections in patients treated with caspofungin. J Infect. 2012;64(4):424–429. doi:10.1016/j.jinf.2011.12.015
  • Bojic M, Willinger B, Rath T, et al. Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview. Mycoses. 2013;56(6):687–689. doi:10.1111/myc.12087
  • Corzo-León DE, Satlin MJ, Soave R, et al. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses. 2015;58(6):325–336. doi:10.1111/myc.12318
  • Heiblig M, Bozzoli V, Saison J, et al. Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient. Mycoses. 2015;58(5):308–312. doi:10.1111/myc.12305
  • Nanno S, Nakane T, Okamura H, et al. Disseminated Hormographiella aspergillata infection with involvement of the lung, brain, and small intestine following allogeneic hematopoietic stem cell transplantation: case report and literature review. Transpl Infect Dis. 2016;18(4):611–616. doi:10.1111/tid.12561
  • Godet C, Cateau E, Rammaert B, et al. Nebulized liposomal amphotericin B for treatment of pulmonary infection caused by Hormographiella aspergillata: case report and literature review. Mycopathologia. 2017;182(7-8):709–713. doi:10.1007/s11046-017-0117-9
  • Chauhan A, Gruenberg J, Arbefeville S, et al. Disseminated Hormographiella aspergillata infection with lung and brain involvement after allogenic hematopoietic stem-cell transplantation in a 54-year-old man. Lab Med. 2019;50(4):426–431. doi:10.1093/labmed/lmz018
  • Isabel Cristina RS, Diana A, Karen A. Breakthrough Hormographiella aspergillata infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis: A case report and review. Mycopathologia. 2020;185(6):1069–1076. doi:10.1007/s11046-020-00488-z
  • Moniot M, Lavergne RA, Morel T, et al. Hormographiella aspergillata: an emerging basidiomycete in the clinical setting? A case report and literature review. BMC Infect Dis. 2020;20(1):945. doi:10.1186/s12879-020-05679-z
  • Tschopp J, Perentes JY, Beigelman-Aubry C, et al. Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: report of two cases successfully treated and review of the literature. Med Mycol Case Rep. 2021;32:68–72. doi:10.1016/j.mmcr.2021.03.008
  • Chong E, Yu HJ, Kim TY, et al. Invasive hormographiella aspergillata infection identified using DNA sequencing. Ann Lab Med. 2022;42(3):370–372. doi:10.3343/alm.2022.42.3.370
  • Delliere S, Rivero-Menendez O, Gautier C, et al. Emerging mould infections: get prepared to meet unexpected fungi in your patient. Med Mycol. 2020;58(2):156–162.
  • Han D, Li Z, Li R, et al. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol. 2019;45(5-6):668–685. doi:10.1080/1040841X.2019.1681933
  • Zhou X, Wu H, Ruan Q, et al. Clinical evaluation of diagnosis efficacy of active mycobacterium tuberculosis complex infection via metagenomic next-generation sequencing of direct clinical samples. Front Cell Infect Microbiol. 2019;9:351. doi:10.3389/fcimb.2019.00351
  • Guo Y, Li H, Chen H, et al. Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue. EBiomedicine. 2021;73:103639. doi:10.1016/j.ebiom.2021.103639
  • Chowdhary A, Agarwal K, Kathuria S, et al. Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract. J Clin Microbiol. 2013;51(2):585–590. doi:10.1128/JCM.02943-12
  • Trubiano JA, Dennison AM, Morrissey CO, et al. Clinical utility of panfungal polymerase chain reaction for the diagnosis of invasive fungal disease: a single center experience. Med Mycol. 2016;54(2):138–146. doi:10.1093/mmy/myv092
  • Yang X, Song Y, Liang T, et al. Application of laser capture microdissection and PCR sequencing in the diagnosis of Coccidioides spp. infection: A case report and literature review in China. Emerg Microbes Infect. 2021;10(1):331–341. doi:10.1080/22221751.2021.1889931
  • Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. 3rd ed. CLSI standard M38 (ISBN 1-56238-830-4 [Print]; ISBN 1-56238-831-2 [Electronic]). Clinical and Laboratory Standards Institute, Wayne, PA, 2017.
  • De Hoog GS, Gerrits van den Ende AH. Molecular diagnostics of clinical strains of filamentous basidiomycetes. Mycoses. 1998;41(5–6):183–189. doi:10.1111/j.1439-0507.1998.tb00321.x
  • Chowdhary A, Agarwal K, Meis JF. Filamentous fungi in respiratory infections. What lies beyond Aspergillosis and Mucormycosis? PLOS Pathog. 2016;12(4):e1005491. doi:10.1371/journal.ppat.1005491
  • Watsky KL, Eisen RN, Bolognia JL. Unilateral cutaneous emboli of Aspergillus. Arch Dermatol. 1990;126(9):1214–1217. doi:10.1001/archderm.1990.01670330094015
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
  • Lau A, Chen S, Sorrell T, et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol. 2007;45(2):380–385. doi:10.1128/JCM.01862-06
  • Li N, Li S, Tan W, et al. Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19. Emerg Microbes Infect. 2021;10(1):1418–1428. doi:10.1080/22221751.2021.1948358
  • Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370(25):2408–2417. doi:10.1056/NEJMoa1401268
  • Chiu CY, Miller SA. Clinical metagenomics. Nat Rev Genet. 2019;20(6):341–355. doi:10.1038/s41576-019-0113-7
  • Stratton CW, Schutzbank TE, Tang YW. Use of metagenomic next-generation sequencing in the clinical microbiology laboratory: A step forward, but not an end-all. J Mol Diagn. 2021;23(11):1415–1421. doi:10.1016/j.jmoldx.2021.09.003
  • Hoenigl M, Salmanton-García J, Walsh TJ, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European confederation of medical mycology in cooperation with the international society for human and animal mycology and the American society for microbiology. Lancet Infect Dis. 2021;21(8):e246–e257. doi:10.1016/S1473-3099(20)30784-2